Tinnitus (Secondary to MH Medication) VA Disability Rating is rated by the U.S. Department of Veterans Affairs under DC 6260 of 38 C.F.R. § 4.87 across 2 severity tiers (30% -- Dizziness and staggering / 10% -- Occasional dizziness). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Tinnitus may develop secondary to ototoxic medications prescribed for service-connected conditions. Maximum schedular rating is 10% bilateral. Rated separately from hearing loss.
Tinnitus (Secondary to MH Medication) (DC 6260) is evaluated under 38 C.F.R. § 4.87 using the ent rating framework. Because it is rated by analogy to the general schedule, the 2 levels below describe the body-system criteria the VA applies — the percentage assigned to Tinnitus (Secondary to MH Medication) depends on the specific findings (range of motion, frequency, severity, or functional loss) documented at the C&P exam and in the medical record.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.